• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

    78.73 -0.87 (-1.09%)
    Streaming Delayed Price Updated: 3:22 PM EDT, Apr 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about ANI Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    News headline image
    Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks
    Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Winners And Losers Of Q4: Elanco (NYSE:ELAN) Vs The Rest Of The Pharmaceuticals Stocks
    Wrapping up Q4 earnings, we look at the numbers and key takeaways for the pharmaceuticals stocks, including Elanco (NYSE:ELAN) and its peers. The pharmaceuti... 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    1 Cash-Producing Stock with Promising Prospects and 2 Facing Challenges
    While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
    Via StockStory
    Topics Economy
    News headline image
    1 Small-Cap Stock for Long-Term Investors and 2 We Turn Down
    Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
    Via StockStory
    ANI Pharmaceuticals Inc (NASDAQ:ANIP) Surges 12% After Q4 Earnings Beat ↗
    Via Chartmill
    News headline image
    Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know
    What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ... 
    Via StockStory
    News headline image
    3 Russell 2000 Stocks We Steer Clear Of
    The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
    Via StockStory
    News headline image
    ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 ↗
    Specializing in branded and generic pharmaceuticals, this sector player reported a notable insider sale amid a stable transaction pattern. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    3 Reasons ANIP is Risky and 1 Stock to Buy Instead
    What a brutal six months it’s been for ANI Pharmaceuticals. The stock has dropped 22.2% and now trades at $73.90, rattling many shareholders. This may have i... 
    Via StockStory
    Topics Supply Chain
    News headline image
    2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Question
    Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
    Via StockStory
    News headline image
    Pharmaceuticals Stocks Q4 Highlights: Ocular Therapeutix (NASDAQ:OCUL)
    As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a... 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    3 Profitable Stocks That Concern Us
    While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
    Via StockStory
    News headline image
    Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment
    Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal (NASDAQ:AMRX) and its peers. The g... 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Generic Pharmaceuticals Q4 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Simply the Best
    As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the generic pharmaceuticals industry, including ANI Pharmaceutica... 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know
    A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. 
    Via StockStory
    Topics Economy Stocks
    News headline image
    ANI Pharma (ANIP) Q4 2025 Earnings Call Transcript ↗
    ANI Pharma (ANIP) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    ANI Pharmaceuticals (NASDAQ:ANIP) Beats Expectations in Strong Q4 CY2025, Stock Jumps 12.4%
    Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) announced better-than-expected revenue in Q4 CY2025, with sales up 29.6% year on year to $247.1 million. The company’s full-year... 
    Via StockStory
    News headline image
    1 Safe-and-Steady Stock Worth Your Attention and 2 That Underwhelm
    A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
    Via StockStory
    News headline image
    3 Small-Cap Stocks That Fall Short
    Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
    Via StockStory
    News headline image
    1 Cash-Producing Stock on Our Buy List and 2 We Brush Off
    Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
    Via StockStory
    Topics Supply Chain
    News headline image
    3 Value Stocks with Questionable Fundamentals
    The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
    Via StockStory
    News headline image
    ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why
    Shares of specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) fell 3.3% in the morning session after investors appeared to take profits as the company announced strong preliminary 2025... 
    Via StockStory
    News headline image
    Stocks making big moves yesterday: OneMain, Nextpower, ANI Pharmaceuticals, Akamai Technologies, and Lemonade
    Check out the companies making headlines yesterday: 
    Via StockStory
    News headline image
    Why ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today
    Shares of specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) jumped 13.6% in the afternoon session after the company provided strong 2026 financial guidance that surpassed analyst... 
    Via StockStory
    Topics Artificial Intelligence Supply Chain
    News headline image
    1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm
    The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
    Via StockStory
    News headline image
    3 Reasons to Avoid ANIP and 1 Stock to Buy Instead
    Since January 2021, the S&P 500 has delivered a total return of 83.6%. But one standout stock has nearly doubled the market - over the past five years, ANI Pharmaceuticals has surged 147% to $77.55 per... 
    Via StockStory
    Topics Stocks Supply Chain
    News headline image
    ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗
    ANI is firing on all cylinders operationally, which makes this exit less about fundamentals and more about portfolio discipline at a moment when expectations might be sky-high. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    3 Healthcare Stocks We’re Skeptical Of
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 15.6% over... 
    Via StockStory
    Topics Stocks
    News headline image
    3 Small-Cap Stocks We’re Skeptical Of
    Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
    Via StockStory
    News headline image
    1 Russell 2000 Stock to Consider Right Now and 2 We Avoid
    The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
    Via StockStory
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.